June 16, 2020
Zachary Silbersher, et al v. Valeant Pharmaceuticals Int'l, et al
Case Number:
20-16176
Court:
Nature of Suit:
Companies
- Adamas Pharmaceuticals Inc.
- Bausch Health Cos. Inc.
- BTG International Inc.
- BTG PLC
- Johnson & Johnson
- Salix Pharmaceuticals, Ltd.
- Taxpayers Against Fraud Education Fund
Government Agencies
- Commonwealth of Massachusetts
- State of Indiana
- State of Maryland
- State of Michigan
- State of Nevada
- State of Tennessee
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 05, 2024
9th Circ. Won't Rethink FCA Disclosure Ruling Against Valeant
A Ninth Circuit panel on Friday denied drugmaker Valeant Pharmaceuticals' request to review its decision to revive a False Claims Act suit accusing Valeant of fraudulently obtaining a patent to extend its monopoly on the drug Apriso.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the parties now
Already a subscriber? Click here to login